1. Autologous transfusion-transmitted Yersinia enterocolitica;Richards, C.; Kolins, J.; Trindale, C.D.;JAMA,1992
2. Septic shock due to Yersinia enterocolitica after autologous transfusion;Sire, J.M.; Michelet, C.; Mesnard, R.;Clin Infect Dis,1993
3. A phase III trial of recombinant human erythropoietin therapy in nonanaemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity and efficacy;Goodenough, L.T.; Price, T.H.; Friedman, K.D.;Transfusion,1994
4. The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low haematocrits: a multicentre randomised, double blind, controlled trial;Price, T.H.; Goodnough, L.T.; Vogler, W.R.;Transfusion,1996
5. The cost effectiveness of preoperative autologous blood donations;Etchason, J.; Petz, L.; Keller, E.;N EnglJ Med,1995